跳至主要内容
临床试验/ITMCTR2000003286
ITMCTR2000003286尚未招募未知

Construction of artificial intelligence health management platform based on dysfunction of Shaoyang for the treatment of metabolic syndrome and prevention of ischemic cerebrovascular disease.

Shanghai Sixth People's Hospital0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. In line with the diagnostic criteria of western medicine namely metabolic syndrome patients.
  • 2. In accordance with the Chinese medicine shaoyang cardinal adverse syndrome of the patients, the age between 18 and 70 years old, men and women are not limited.
  • 3. Informed consent, signed informed consent, and voluntary test.

排除标准

  • 1. Pregnant or lactating women;
  • 2. Type 1 diabetes and gestational diabetes and other types of diabetes, secondary hypertension and/or hyperlipidemia;
  • 3. There are serious complications such as heart, liver, kidney or other serious primary diseases associated with mental illness patients.

研究者

发起方
Shanghai Sixth People's Hospital

相似试验